# Abvc Biopharma, Inc.: Form 8-K/A, filed Aug 12, 2026

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K/A
- Filed: 2026-08-12
- Accepted by EDGAR: Aug 12, 2026, 11:50 ET
- Period: 2026-08-03
- Accession: 0001213900-26-088165
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/ea0301755-8ka1_abvc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/ea0301755-8ka1_abvc.htm

Filed Aug 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-088165. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
